You are here: Industry Insights > Truvada

News List

First Long-Acting Injectable Approved for HIV PrEP drugs.com
December 21, 2021
The U.S. Food and Drug Administration has approved the first long-acting injectable treatment for HIV preexposure prophylaxis, which is given every two months and offers an alternative to daily oral medication, the agency announced Monday.
PrEP HIV Prevention Pills to Be Free for Insured Americans drugs
July 22, 2021
Nearly all health insurers must cover the entire cost of HIV prevention treatments, the U.S. government says. That includes the two approved pre-exposure prophylaxis(PrEP) drugs Truvada and Descovy, all clinic visits, and lab tests, NBC News reported.
Gilead 4Q Revenues up 26% contractpharma
February 10, 2021
Revenue growth for the quarter and full year was primarily due to the launch of Veklury (remdesivir).
Long-acting injectable HIV PrEP outperforms commercially available daily pill europeanpharmaceuticalreview
July 09, 2020
Extensive analysis of interim data finds patients given cabotegravir injection had a 66 percent lower incidence of HIV acquisition than those taking Truvada pills.
GSK’s long-acting injection beats Truvada in HIV prevention trial expresspharma
May 19, 2020
Truvada generated $2.8 billion in sales last year, both from treatment and preventing an HIV infection.
U.S. Reps to Gilead: Did your donation of free HIV prevention drug Truvada have strings attached? fiercepharma
July 04, 2019
In May, Gilead pledged to donate 2.4 million bottles of its HIV drug Truvada to the U.S. government’s effort to eradicate the disease, partly by preventing new infections. Gilead even promised it would donate its newer drug, Descovy, if the FDA approves i
Lawmakers clash as Gilead CEO takes congressional hot seat to defend Truvada fiercepharma
May 21, 2019
Gilead Sciences' important HIV business has been under fire in recent weeks, with lawsuits and critics airing allegations about the company’s pricing, patents and more.
Gilead to donate 2.4M bottles of Truvada in push to limit HIV infections fiercepharma
May 13, 2019
With HIV rates in the U.S. holding steady, health officials are looking to drugmakers for help containing its spread.
Generic Version of Truvada Available in U.S. by Sept. 2020 drugs
May 10, 2019
Generic Version of Truvada Available in U.S. by Sept. 2020.
Trump's HIV pledge comes as Gilead pumps cash into Truvada for PrEP fiercepharma
February 24, 2019
Gilead is looking to eventually sub out Truvada for its newer HIV drug Descovy when it comes to pre-exposure prophylaxis. But in the meantime, it’s socking cash into promoting the older brand for PrEP.

Previous page 1 2 Next page